Signal
Unravel Health Secures €2.96 Million Seed for Rapid At-Home Salivary Hormone Diagnostic
- Category
- · Funding · Global
- Date
- October 19, 2026
- Source
- OVUM
Summary
London-based Unravel Health has raised €2.96 million to finalize its Micro Lab, a palm-sized device capable of measuring multiple hormones including oestradiol from saliva in minutes. The funding will accelerate the shift from central lab testing to daily, longitudinal home monitoring for women.
The company works in Diagnostics and Devices, and this round at Seed ($2.96M) is new money into that part of the market. Compare it with other recent rounds to see whether prices here are rising or holding steady.
OVUM interpretation layer
The editorial read on this signal — pattern, market-structure implications, and what to watch next.
Sources
- OVUM Primary source
The OVUM Intelligence Brief
Keep reading past this page
The week's funding, launches, and studies in women's health, in plain English.
Weekly. No spam. Unsubscribe anytime.